CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-15 | Dreyer Scott EVP & Chief Commercial Officer | Sale | −1,322 | $22.89 | $30K | 44,395 |
| 2021-01-11 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −701 | $21.18 | $15K | 45,717 |
| 2021-01-07 | Fleming Alison B Chief Technology Officer | Option exercise | +16,042 | $5.73 | $92K | 127,461 |
| 2021-01-07 | Fleming Alison B Chief Technology Officer | Sale | −16,042 | $22.00 | $353K | 111,419 |
| 2021-01-07 | Fleming Alison B Chief Technology Officer | Option exercise · Stock Option (Right to Purchase) | −16,042 | 0 | ||
| 2021-01-04 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −1,090 | $20.03 | $22K | 184,256 |
| 2020-12-03 | Fleming Alison B Chief Technology Officer | Sale | −5,967 | $19.24 | $115K | 111,419 |
| 2020-11-30 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −4,672 | $18.49 | $86K | 185,346 |
| 2020-11-18 | Fleming Alison B Chief Technology Officer | Option exercise | +16,000 | $5.73 | $92K | 117,386 |
| 2020-11-18 | Fleming Alison B Chief Technology Officer | Option exercise · Stock Option (Right to Purchase) | −16,000 | 19,378 | ||
| 2020-10-15 | Kuhlmann Shirley R. EVP and General Counsel | Sale | −7,060 | $20.82 | $147K | 57,531 |
| 2020-09-24 | Balice-Gordon Rita J. Director | Grant or award | +5,027 | 5,027 | ||
| 2020-09-24 | Balice-Gordon Rita J. Director | Grant or award · Stock Option (Right to Purchase) | +10,055 | 10,055 | ||
| 2020-09-16 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −734 | $19.33 | $14K | 64,591 |
| 2020-08-11 | Heffernan Michael Thomas Director | Sale | −13,071 | $19.13 | $250K | 54,122 |
| 2020-08-10 | Brannelly Paul Executive Vice President & CFO | Shares withheld for taxes | −1,515 | $18.89 | $29K | 173,758 |
| 2020-08-10 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −1,386 | $18.89 | $26K | 190,018 |
| 2020-08-10 | Fleming Alison B Chief Technology Officer | Shares withheld for taxes | −1,515 | $18.89 | $29K | 101,386 |
| 2020-07-13 | Dreyer Scott EVP & Chief Commercial Officer | Sale | −1,429 | $17.01 | $24K | 46,418 |
| 2020-07-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −594 | $16.73 | $10K | 47,847 |
Page 21 of 24 · 462 trades